A multisite trial of a clinic-integrated intervention for promoting family management of pediatric type 1 diabetes: feasibility and design.

A multisite trial of a clinic-integrated intervention for promoting family management of pediatric type 1 diabetes: feasibility and design.
复制标题

促进儿科 1 型糖尿病家庭管理的临床综合干预的多中心试验:可行性和设计。

DOI:
10.1111/j.1399-5448.2008.00448.x
复制
发表时间:
2009-04
期刊:
影响因子:
3.4
通讯作者:
Lochrie AS
Lochrie AS
中科院分区:
医学3区
文献类型:
--
作者:
Nansel TR;Anderson BJ;Laffel LM;Simons-Morton BG;Weissberg-Benchell J;Wysocki T;Iannotti RJ;Holmbeck GN;Hood KK;Lochrie AS

文献摘要

参考文献

被引文献

相似文献

以家庭为基础的临床综合行为干预,以改善1型糖尿病的家庭管理的可行性进行了评估。在四个临床站点中的每一个中,30至32个家庭(总共122个)被随机分配到干预组或常规护理对照组。在3次例行诊所访问期间,由经过培训的“健康顾问”提供基于家庭问题解决方法的WE*CAN干预措施。在四个地点符合条件的家庭中,83%同意参与,其中96%完成了基线,中期和干预后评估。在8个月期间,家庭平均参加了2.85次干预会议。干预措施被整合到诊所环境中,而不影响诊所流程,并由经过培训的非专业人员在各研究中心以保真度和一致性实施。研究结果提供了证据的可行性进行多地点试验,以评估临床综合解决问题的干预措施,以改善家庭管理的影响。许多经验教训,为更大规模的临床试验的招募,测量和干预提供了指导。
The feasibility of a family-based clinic-integrated behavioral intervention to improve family management of type 1 diabetes was evaluated. In each of four clinical sites, 30 to 32 families (122 total) were randomized to intervention or usual care comparison group. The WE*CAN intervention, based on family problem-solving methods, was delivered during 3 routine clinic visits by trained “Health Advisors”. Of eligible families across the four sites, 83% agreed to participate, of whom 96% completed the baseline, mid-term, and post-intervention assessments. Families participated in an average of 2.85 intervention sessions over an 8-month period. The intervention was integrated into the clinic setting without impairing clinic flow, and was implemented with fidelity and consistency across sites by trained non-professionals. The findings provide evidence of the feasibility of conducting a multi-site trial to evaluate the effects of a clinic-integrated problem-solving intervention to improve family management. Many lessons were learned that provide guidance for recruitment, measurement, and intervention for the larger clinical trial.
DOI: 10.1093/jpepsy/jsh005
发表时间: 2004-01-01
影响因子: 3.6
作者:
Palmer, DL;Berg, CA;Donaldson, DL
通讯作者: Donaldson, DL
DOI: 10.2337/diacare.24.9.1536
发表时间: 2001-09-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Bryden, KS;Peveler, RC;Dunger, DB
通讯作者: Dunger, DB
DOI: 10.1067/mpd.2000.106568
发表时间: 2000-07-01
影响因子: 5.1
作者:
Grey, M;Boland, EA;Tamborlane, WV
通讯作者: Tamborlane, WV
DOI: 10.2337/diacare.12.3.179
发表时间: 1989-03-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
ANDERSON, BJ;WOLF, FM;BACON, GE
通讯作者: BACON, GE
DOI: 10.1093/jpepsy/26.2.123
发表时间: 2001-03-01
影响因子: 3.6
作者:
Davis, CL;Delamater, AM;Nemery, R
通讯作者: Nemery, R